etoposide has been researched along with Cancer of Oropharnyx in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, S; Baghmar, S; Bhasker, S; Chander, S; Gogia, A; Kumar, R; Nath, D; Sahai, P; Sikka, K | 1 |
| Löhr, G; Musil, J; Nagel, GA; Rauschning, W; Schröder, M; Schuff-Werner, P | 1 |
1 trial(s) available for etoposide and Cancer of Oropharnyx
| Article | Year |
|---|---|
[Effect of thymostimulin on chemotherapy-induced changes in lymphocyte subset distribution. A longitudinal study in patients with primary inoperable oropharyngeal cancers].
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunotherapy; Longitudinal Studies; Lymphocytes; Oropharyngeal Neoplasms; Pharyngeal Neoplasms; Thymus Extracts | 1987 |
1 other study(ies) available for etoposide and Cancer of Oropharnyx
| Article | Year |
|---|---|
Extrapulmonary Small Cell Carcinoma - a Case Series of Oropharyngeal and Esophageal Primary Sites Treated with Chemo-Radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Oropharyngeal Neoplasms; Palliative Care | 2015 |